Duke-NUS launches LIVE Ventures to boost commercialisation of academic research
Duke-NUS Medical School today launched LIVE Ventures, a S$20 million incubation programme designed to catalyse the commercialisation of innovative academic research. Aimed at translating scientific breakthroughs into clinical applications, LIVE Ventures will provide Duke-NUS scientists conducting high-impact research with essential commercialisation expertise and resources, and partner with both public and private sector entities to co-fund…